Journal
ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA
Volume 27, Issue 4, Pages 479-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.coms.2015.06.008
Keywords
Osteonecrosis; Medication-related osteonecrosis of the jaw; Jaw necrosis; Antiresorptive therapy; Antiangiogenic therapy
Categories
Ask authors/readers for more resources
The relationship between osteonecrosis of the jaw and bisphosphonate therapy was initially established more than 10 years ago. Since that time, our understanding of this disease process has evolved as the direct result of clinical, basic science, and animal research initiatives. Medication-related osteonecrosis of the jaw (MRONJ) is a well-known entity now known to be associated with various antiresorptive therapies and recently with antiangiogenic medications. This article reviews the recently modified diagnostic criteria for MRONJ with a focus on the clinical, histopathologic, and imaging characteristics of this disease process.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available